Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mTOR and Activation of p38-MAPK Signaling Pathways in Hep3B Liver Cancer Cells by Prunetrin—A Flavonoid with Therapeutic Potential
Authors:
- Abuyaseer AbusaliyaAbuyaseer Abusaliya
- Se Hyo JeongSJSe Hyo Jeong
- Pritam Bhagwan BhosalePBPritam Bhagwan Bhosale
- Hun Hwan KimHKHun Hwan Kim
- Min Yeong ParkMPMin Yeong Park
- Eunhye KimEKEunhye Kim
- Chung Kil WonCWChung Kil Won
- Kwang Il ParkKPKwang Il Park
- Jeong Doo HeoJHJeong Doo Heo
- Hyun Wook KimHKHyun Wook Kim
- Meejung AhnMAMeejung Ahn
- Je Kyung SeongJSJe Kyung Seong
Open Access
Abstract
Hepatocellular carcinoma (HCC) has a poor prognosis and a low survival rate. Drugs without side effects are desperately needed since chemotherapy has a negative effect on the host cells. Previous research has firmly established that plant-based compounds have significant bioactivities without a negative impact on the host. Flavonoids, in particular, are a class of compounds with both anti-inflammatory and anti-cancer properties. Prunetrin (PUR) is a glycosyloxyisoflavone (Prunetin 4′-O-glucoside) derived from Prunus sp., and its other form, called prunetin, showed optimistic results in an anti-cancerous study. Hence, we aimed to discover the anti-cancer ability of prunetrin in liver cancer Hep3B cells. Our cytotoxicity results showed that PUR can decrease cell viability. The colony formation assay confirms this strongly and correlates with cell cytotoxicity results. Prunetrin, in a dose-dependent manner, arrested the cell cycle in the G2/M phase and decreased the expression of cyclin proteins such as Cyclin B1, CDK1/CDC2, and CDC25c. Prunetrin treatment also promoted the strong cleavage of two important apoptotic hallmark proteins called PARP and caspase-3. It also confirms that apoptosis occurs through the mitochondrial pathway through increased expression of cleaved caspase-9 and increased levels of the pro-apoptotic protein Bak. Bak was significantly increased with the declining expression of the anti-apoptotic protein Bcl-xL. Next, it inhibits the mTOR/AKT signaling pathways, proving that prunetrin includes apoptosis and decreases cell viability by suppressing these pathways. Further, it was also observed that the activation of p38-MAPK was dose-dependent. Taken together, they provide evidence that prunetrin has an anti-cancerous ability in Hep3B liver cancer cells by arresting the cell cycle via p38 and inhibiting mTOR/AKT.Keywords
Funding Information
- National Research Foundation (2022R1A6A3A01086899, RS-2023-00243376)
This publication has 55 references indexed in Scilit:
- Regulation of the Intrinsic Apoptosis Pathway by Reactive Oxygen SpeciesAntioxidants & Redox Signaling, 2013
- Cotargeting MAPK and PI3K Signaling with Concurrent Radiotherapy as a Strategy for the Treatment of Pancreatic CancerMolecular Cancer Therapeutics, 2012
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- MAPK signaling in inflammation-associated cancer developmentProtein & Cell, 2010
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Cytochrome c: functions beyond respirationNature Reviews Molecular Cell Biology, 2008
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in ApoptosisJournal of Biological Chemistry, 1999
- Mitochondrial control of apoptosis: the role of cytochrome cBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998